| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
15,110,000 |
| Market
Cap: |
4.08(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2701 - $0.2701 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Artelo Biosciences is a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signalling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. Co. is developing a G protein-coupled receptor targeting synthetic small molecule program, ART27.13, as a treatment for anorexia associated with cancer; ART26.12, which a small molecule inhibitor of Fatty Acid Binding Protein 5, for cancer therapeutic and anxiety-related disorder, including post-traumatic stress disorder; and ART12.11, a solid-state composition of cannabidiol.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,400 |
| Total Buy Value |
$0 |
$0 |
$0 |
$9,636 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2022-08-12 |
4 |
B |
$4.00 |
$4,800 |
I/I |
1,200 |
2,400 |
0.01 |
-100% |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2022-08-11 |
4 |
B |
$4.03 |
$4,836 |
I/I |
1,200 |
1,200 |
0.01 |
-100% |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2021-04-16 |
4 |
B |
$1.15 |
$9,809 |
D/D |
8,500 |
270,676 |
0.01 |
-20% |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2020-05-15 |
4 |
B |
$1.21 |
$5,072 |
D/D |
4,200 |
262,176 |
0.01 |
-42% |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2020-05-04 |
4 |
B |
$1.20 |
$5,000 |
D/D |
4,167 |
257,976 |
0.01 |
-31% |
|
| Matsui Connie |
|
– • – |
2020-05-04 |
4 |
B |
$1.20 |
$50,000 |
D/D |
41,667 |
56,667 |
0.01 |
-31% |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-11-04 |
4 |
B |
$2.21 |
$5,304 |
D/D |
2,400 |
253,809 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-11-01 |
4 |
B |
$2.28 |
$5,702 |
D/D |
2,500 |
251,409 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-11-01 |
4 |
B |
$2.28 |
$5,702 |
D/D |
2,500 |
251,409 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-31 |
4 |
B |
$1.95 |
$4,875 |
D/D |
2,500 |
248,909 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-31 |
4 |
B |
$1.95 |
$4,875 |
D/D |
2,500 |
248,909 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-30 |
4 |
B |
$1.99 |
$5,186 |
D/D |
2,600 |
246,409 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-30 |
4 |
B |
$1.99 |
$5,186 |
D/D |
2,600 |
246,409 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-15 |
4 |
B |
$2.05 |
$5,333 |
D/D |
2,600 |
243,809 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-15 |
4 |
B |
$2.05 |
$5,333 |
D/D |
2,600 |
243,809 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-11 |
4 |
B |
$1.96 |
$5,296 |
D/D |
2,700 |
241,209 |
0.01 |
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • – |
2019-10-11 |
4 |
B |
$1.96 |
$5,296 |
D/D |
2,700 |
241,209 |
0.01 |
- |
|
| Obrien Peter Michael |
|
– – • |
2019-09-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(17,500) |
7,500 |
|
- |
|
| Obrien Peter Michael |
|
– – • |
2019-09-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(17,500) |
7,500 |
|
- |
|
| Moss David J |
|
– – • |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
223,194 |
|
- |
|
| Gorgas Gregory D. |
Pres, CEO, CFO, Treas & Secr |
• • • |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
238,509 |
|
- |
|
| Erbez Georgia |
|
– • – |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,500 |
|
- |
|
| Obrien Peter Michael |
|
– – • |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,000 |
|
- |
|
| Obrien Peter Michael |
|
– – • |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
337,500 |
|
- |
|
| Blayney Douglas |
|
– • – |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,500 |
|
- |
|
28 Records found
|
|
Page 1 of 2 |
|
|
